Provision of Bypassing Agents for the treatment of Haemophilia or related disorders with inhibitors

Description

Provision of Bypassing Agents for the treatment of Haemophilia or related disorders with inhibitors This procurement process is being undertaken by the Board of St James’s Hospital, James Street Dublin 8 on behalf of the CA. For clarity the primary customer and the contract holder will be the Board of St James’s Hospital. The CA reserves the right without advance notice (and without giving reasons, unless so required) to amend or otherwise change the process or to terminate the process. This ITT document does not represent a commitment to enter into any contract. There will be two lots. Lot 1 – Plasma Derived Product Lot 2 – Recombinant Product Lot 1: Plasma Derived Product This procurement process is being undertaken by the Board of St James’s Hospital, James Street Dublin 8 on behalf of the CA. For clarity the primary customer and the contract holder will be the Board of St James’s Hospital. The CA reserves the right without advance notice (and without giving reasons, unless so required) to amend or otherwise change the process or to terminate the process. This ITT document does not represent a commitment to enter into any contract. There will be two lots. Lot 1 – Plasma Derived Product Lot 2 – Recombinant Product Lot 2: Recombinant Product This procurement process is being undertaken by the Board of St James’s Hospital, James Street Dublin 8 on behalf of the CA. For clarity the primary customer and the contract holder will be the Board of St James’s Hospital. The CA reserves the right without advance notice (and without giving reasons, unless so required) to amend or otherwise change the process or to terminate the process. This ITT document does not represent a commitment to enter into any contract. There will be two lots. Lot 1 – Plasma Derived Product Lot 2 – Recombinant Product